Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TrueMRI is a medical technology company specializing in quantitative magnetic resonance imaging (MRI) through its proprietary Magnetic Resonance Fingerprinting (MRF) technology. Developed as a spin-off from Case Western Reserve University, the company's platform enables the simultaneous acquisition of multiple physical tissue properties in a single, rapid scan. Unlike traditional MRI, which produces qualitative images subject to interpreter variability, TrueMRI's approach generates objective, reproducible data points for each tissue type. This technology is designed to improve diagnostic precision, treatment monitoring, and clinical trial efficiency in therapeutic areas such as neurology and oncology. By standardizing imaging across different scanner manufacturers and clinical sites, TrueMRI facilitates more reliable longitudinal patient care and data-driven medical decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TrueMRI.